| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/17/1998 | WO1998040353A1 Novel heterocyclic compounds |
| 09/17/1998 | WO1998040344A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 09/17/1998 | WO1998040105A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 09/17/1998 | WO1998040099A1 Leptospira pathogens |
| 09/17/1998 | WO1998040097A2 Bovine respiratory and enteric coronavirus as a vaccine |
| 09/17/1998 | WO1998040096A1 Preventives and/or remedies for multiple organ failure |
| 09/17/1998 | WO1998040093A1 Method of antagonizing the human src sh2 domain |
| 09/17/1998 | WO1998040088A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 09/17/1998 | WO1998040087A2 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION |
| 09/17/1998 | WO1998040086A2 Essential oil composition |
| 09/17/1998 | WO1998040085A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate |
| 09/17/1998 | WO1998040080A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/17/1998 | WO1998040079A1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040064A1 Butyrate prodrugs derived from lactic acid |
| 09/17/1998 | WO1998040061A1 Use of r-nsaid's for the prevention of alzheimer's disease |
| 09/17/1998 | WO1998040056A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 09/17/1998 | WO1998039970A1 Quinoline leukotriene antagonists |
| 09/17/1998 | WO1998028282A3 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19711052A1 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic agent |
| 09/17/1998 | DE19710054A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 09/17/1998 | CA2285446A1 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284183A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate |
| 09/17/1998 | CA2283624A1 Leptospira pathogens |
| 09/17/1998 | CA2283580A1 Use of human .alpha.1-acid glycoprotein for producing a pharmaceutical preparation |
| 09/17/1998 | CA2283472A1 Method of antagonizing the human src sh2 domain |
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283184A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2283162A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/17/1998 | CA2283108A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 09/17/1998 | CA2282710A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | CA2282398A1 Inhibitors of impdh enzyme |
| 09/17/1998 | CA2282349A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | CA2252711A1 An agent for preventing and/or treating multiple organ failure |
| 09/16/1998 | EP0864327A1 Use of pyrimidin derivatives to prevent cancer |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0864087A1 Combinatorial dihydrobenzopyran library |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863905A1 Novel imidazole lipoxygenase inhibitors |
| 09/16/1998 | EP0863902A1 2'- 4'-HALO- 1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO CYCLOPENTANE-1,7'(8'H)- 3H]IMIDAZO 2,1-b]PURIN]-4'(5'H)-ONES |
| 09/16/1998 | EP0863897A1 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht 4? or h 3? receptor ligands |
| 09/16/1998 | EP0863896A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 09/16/1998 | EP0863891A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863882A1 Amino substituted pyrimidines and triazines |
| 09/16/1998 | EP0863873A1 Indole carbamates as leukotriene antagonists |
| 09/16/1998 | EP0863769A1 Glycoconjugates as virus cell adhesion inhibitors |
| 09/16/1998 | EP0863762A1 Methods of production and use of liquid formulations of plasma proteins |
| 09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 09/16/1998 | EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 09/16/1998 | EP0728128B1 Substituted phenyl compounds |
| 09/16/1998 | EP0699442B1 Use of a strain of the fungus fusarium as a producer of substances and a preparation based on said substances with adaptogenic and immunomodulating properties |
| 09/16/1998 | EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 09/16/1998 | EP0570380B1 Novel methylenebisphosphonic acid derivatives |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | EP0485430B1 Methods and compositions for ameliorating the symptoms of sepsis |
| 09/16/1998 | CN1193325A Cell adhension inhibitors |
| 09/16/1998 | CN1193313A Propynyl or dienyl diaromatic compounds |
| 09/16/1998 | CN1193276A Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/16/1998 | CN1192904A Composite preparation for treatment of dementia |
| 09/15/1998 | US5808137 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumors |
| 09/15/1998 | US5808061 Intermediates and processes for preparing benzothiophene compounds |
| 09/15/1998 | US5807890 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/15/1998 | US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction |
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807876 Inosine-5'-monophospate dehydrogenase; viral diseases, cancer, vascular diseases; merimepodib |
| 09/15/1998 | US5807875 Obesity therapy |
| 09/15/1998 | US5807870 Substituted pipecolinic acid derivatives as HIV protease inhibitors |
| 09/15/1998 | US5807867 Quinuclidine derivatives |
| 09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
| 09/15/1998 | US5807857 Migraine |
| 09/15/1998 | US5807852 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 09/15/1998 | US5807851 2,3-Benzodiazepine Derivatives as non-competitive AMPA |
| 09/15/1998 | US5807847 Nitrate esters |
| 09/15/1998 | US5807839 Method for stimulating red blood cell production |
| 09/15/1998 | US5807833 Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
| 09/15/1998 | US5807829 Serine protease inhibitor--tripeptoid analogs |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807819 Using an oligopeptide |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807691 Polypeptides having serotonin receptor activity (5HT5A), nucleic acids coding for these polypeptides and uses thereof |
| 09/15/1998 | US5807689 Bioanalysis |
| 09/15/1998 | US5807600 Using salts of a-hydroxyacids |
| 09/15/1998 | US5807570 Dopamine agonist |
| 09/15/1998 | US5807564 Method of strengthening antibacterial action of antibiotics |
| 09/15/1998 | CA2122815C 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 09/15/1998 | CA2006269C 1,4-dideoxy-1,4-imino-l-allitol and its n-substituted alkyl and benzyl derivatives |
| 09/15/1998 | CA2001750C Pyrrolidine derivatives |
| 09/15/1998 | CA1340047C 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid, a process for the preparation thereof, the use thereof as pharmaceuticals, and intermediates |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/13/1998 | CA2231765A1 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures |